Breaks Categories: News

MondayJun 27, 2022 1:36 pm

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Featured in Adelaide Capital Biofuels & Renewable Energy Panel

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, was recently featured in a virtual biofuels & renewables focused session with a keynote followed by three 20-minute company presentations and a 30-minute panel. EverGen’s co-founder and CEO Chase Edgelow joined the session with host Deborah Honig to discuss the portfolio of assets the company has built over the previous two years. EverGen has built these assets with the view that it is operating at the intersection of organic waste, which needs a long-term sustainability focused solution versus traditional land-filling organics, as well as providing green energy through…

Continue Reading

MondayJun 27, 2022 11:18 am

NetworkNewsBreaks – TiiCKER Featured in CryptoCurrencyWire Production

IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting companies to the investment community, has announced the release of the latest CryptoCurrencyWire production as part of its sustained effort to provide specialized content distribution via widespread syndication channels. According to the update, the latest production features Jeff Lambert (“Tii:JEFE”), founder and CEO of TiiCKER, the first intelligent software platform that engages, verifies and rewards retail shareholders with stock perks. “TiiCKER really came out of frustration,” Lambert said during the interview. “I’ve been doing investor relations for public companies for 25 years, and we could never connect with individual investors. During…

Continue Reading

FridayJun 24, 2022 1:25 pm

NetworkNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Focused on LW Solutions as Bitcoin’s Reputation Shifting to Medium of Exchange

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LW”), is working toward its goals by adding more nodes on the LW. “The company has increased its total number of nodes on the LW to 17. The company recently added new nodes in Canada, South Korea, Brazil, Hong Kong, South Africa, Bahrain, and Japan. These new ones join previously launched nodes in the U.S., Ireland, India, Germany, Singapore, Sweden, Indonesia, Italy, France, and England,” a recent article reads. “Because Bitcoin blockchain transactions are notoriously slow and expensive, the…

Continue Reading

FridayJun 24, 2022 12:24 pm

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) Becomes Among Sector’s 1st to Ensure Real-Time Custodial Account Attestations

GreenBox (NASDAQ: GBOX) is a financial technology company that leverages proprietary blockchain security and token technology to deliver customized payment solutions. The company has consistently called for improved processes to make the stablecoin industry custodial and transactional — the two elements GreenBox believes are critical to the industry’s long-term success. Upon completing a rigorous process, GreenBox has announced a partnership with accounting and consulting firm Armanino to attest to all GreenBox custodial accounts in real-time. “I could not be more pleased to see the stablecoin industry and the regulators move in the direction GreenBox has built our company on since…

Continue Reading

FridayJun 24, 2022 11:36 am

NetworkNewsBreaks – Feutune Light Acquisition Corporation (NASDAQ: FLFVU) Announces Pricing of $85M IPO

Feutune Light Acquisition Corporation (NASDAQ: FLFVU) recently announced the pricing of its initial public offering (“IPO”) of 8,500,000 units at a price of $10.00 per unit. The units commenced listing on The NASDAQ Global Market (“NASDAQ”) and trade under the symbol FLFVU. According to the update, each unit issued in the IPO consists of one share of Class A common stock, one redeemable warrant and one right to receive one-tenth (1/10) of one share of Class A common stock. Each warrant is exercisable to purchase one whole share of Class A common stock, each at a price of $11.50. Once…

Continue Reading

ThursdayJun 23, 2022 4:46 pm

NetworkNewsBreaks – Canaan Inc. (NASDAQ: CAN) Announces Repurchase of Outstanding Warrants for ~$6.61M

Canaan (NASDAQ: CAN), a leading high-performance computing solutions provider, has announced its entry into agreements with certain warrant holders to repurchase over 4.72 million outstanding warrants of the company for an aggregate purchase price of approximately US$6.61 million. According to the update, the company issued the warrants in May 2021 pursuant to (i) certain securities purchase agreement (the “SPA”) between the company and the purchasers party thereto, dated April 29, 2021, and (ii) certain placement agent agreement between the company and the placement agents thereto, dated April 29, 2021. Simultaneously, the parties amended the terms of the SPA in a…

Continue Reading

ThursdayJun 23, 2022 4:40 pm

NetworkNewsBreaks – BIT Mining Limited (NYSE: BTCM) Announces $16M Registered Direct Offering

BIT Mining (NYSE: BTCM), a leading technology-driven cryptocurrency mining company, today announced its entry into a securities purchase agreement with certain institutional investors. The registered direct offering is for the purchase and sale of 16,000,000 of the company's American Depositary Shares (“ADSs”) (or pre-funded warrant to purchase certain ADSs (“ADS Equivalent”) in lieu thereof), Series A Warrants to purchase up to an aggregate of 16,000,000 ADSs and Series B Warrants to purchase up to an aggregate of 16,000,000 ADSs, at a combined purchase price of US$1.00 per ADS (or ADS Equivalent) and associated warrants. Each ADS represents ten (10) Class…

Continue Reading

ThursdayJun 23, 2022 4:35 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced its receipt of approval from the U.S. Food and Drug Administration (“FDA”) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We are pleased to have received this positive response from the FDA and to continue driving the…

Continue Reading

ThursdayJun 23, 2022 3:19 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update to its shareholders, including recent highlights and accomplishments for the company, the Mullen FIVE and the Mullen EV Van programs. Among the various highlights, the company reported that its solid-state polymer battery cell was successfully tested for the second time at Battery Innovation Center (“BIC”) in Indiana. The follow-up testing through an accredited facility shows promise for solid-state polymer cell technology when scaled to the vehicle pack level and used in EVs. “2022 has been an exceptional year for us so far; I am very proud…

Continue Reading

ThursdayJun 23, 2022 2:56 pm

NetworkNewsBreaks – Silo Pharma Inc. (SILO) Announces Expansion of License Agreement and Patent Portfolio

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that it has expanded its commercial evaluation license agreement (“CELA”) with the University of Maryland Baltimore (“UMB”) for its next-generation liposomal peptide targeting autoimmune diseases. “We are delighted to expand our partnership with UMB. Pre-clinical testing of these peptides has shown positive results in animal studies. The three-phage peptides we identified specifically target inflamed vascular endothelium of arthritic joints in an adjuvant-induced arthritis rat model,” said Eric Weisblum, CEO of Silo Pharma. “To test the therapeutic effect of the peptides, arthritic…

Continue Reading